Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Neoplasms 1 Death 1 Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 17 Bevacizumab 12 Standard of Care 10 Cyclophosphamide 9 Carboplatin 9 Doxorubicin 7 Cetuximab 7 Nivolumab 6 Exercise 6 olaparib 5 atezolizumab 5 Rituximab 5 Radiotherapy 5 Pemetrexed 5 Fluorouracil 5 Cisplatin 5 durvalumab 4 dostarlimab 4 abemaciclib 4 Temozolomide 4 Prednisone 4 Paclitaxel 4 Leucovorin 4 Blood Specimen Collection 4 venetoclax 3 temsirolimus 3 talazoparib 3 pertuzumab 3 obinutuzumab 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Focus Groups × 30 days × Clear all

NCT06786104 2026-05-14

VIDEO-PEDS

Massachusetts General Hospital

Phase NA Recruiting

Death, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡